lapatinib has been researched along with Carcinoma, Lewis Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, C; Wang, B; Xue, L; Yin, S; Zhang, C; Zhang, Y; Zhou, L | 1 |
1 other study(ies) available for lapatinib and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Heterografts; Humans; Mice; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2 | 2016 |